Physiogenex is a leading preclinical research organization (CRO) specializing in metabolic disorders such as diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications.

We provide:

- Classical and proprietary diet-induced in vivo models
- Innovative in-house techniques (RCT)  and gold standard methods (glucose clamps with radiolabelled tracers, …)
- In vivo preclinical imaging services

Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions for successful strategic decision-making.

Physiogenex

Org chart

Teams

Offices